| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/01/2012 | CN1914226B SARS-CoV抗体及其使用方法 SARS-CoV antibodies and the use of |
| 02/01/2012 | CN102341496A Humanized pcrv antibody having anti-pseudomonal activity |
| 02/01/2012 | CN102341412A Fully human antibodies specific to CADM1 |
| 02/01/2012 | CN102341411A Anti-lymphotoxin antibodies |
| 02/01/2012 | CN102341121A Anti-rhesus d monoclonal antibody |
| 02/01/2012 | CN102337287A Construction and expression of recombinant 20kD human growth hormone expression vector, preparation of monoclonal antibody, and cell strain secreting the monoclonal antibody |
| 02/01/2012 | CN102337218A Factor for regulating toxicity of Candida albicans and its application |
| 02/01/2012 | CN102336834A Fully human TNFalpha-Fab antibody and its PEG antibody |
| 02/01/2012 | CN102336833A CHD1L-TCTP binding blocking agent as well as medical combination with same and application thereof |
| 02/01/2012 | CN102336832A Heavy chain and domain antibodies |
| 02/01/2012 | CN102336831A Anti-sildenafil specific antibody |
| 02/01/2012 | CN102336830A Anti-nandrolone specific antibody |
| 02/01/2012 | CN102336814A Polypeptide sequence for preparing anti-liver-neoplasm marker CK-19 antibody, polyclonal antibody and application thereof |
| 02/01/2012 | CN101942415B 一种杂交瘤细胞株及其产生的抗盐酸克伦特罗单克隆抗体 One kind of hydrochloric acid and the resulting hybridoma cell line anti-clenbuterol monoclonal antibodies |
| 02/01/2012 | CN101912609B 防治绿脓杆菌感染的组合物及其制备方法 Pseudomonas aeruginosa infection prevention composition and its preparation method |
| 02/01/2012 | CN101389654B 新的用于肝脏疾病的非侵入性标记 Liver disease for a new non-invasive marker |
| 01/31/2012 | US8106170 Compositions against SARS-coronavirus and uses thereof |
| 01/31/2012 | US8106169 Plant production of immunoglobulins with reduced fucosylation |
| 01/31/2012 | US8106168 Metalloproteinase binding proteins |
| 01/31/2012 | US8106167 Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
| 01/31/2012 | US8106166 Antibodies that bind specifically to phosphorylated β-catenin |
| 01/31/2012 | US8106165 Antibodies to HNFIP24 polypeptides |
| 01/31/2012 | US8106164 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 01/31/2012 | US8106163 Compositions and methods of use for therapeutic antibodies |
| 01/31/2012 | US8106162 Artificial antibody polypeptides |
| 01/31/2012 | US8106161 Binding domain-immunoglobulin fusion proteins |
| 01/31/2012 | US8106158 Compositions and methods for fusion protein separation |
| 01/31/2012 | US8106156 PRO1120 polypeptides |
| 01/31/2012 | US8106018 Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof |
| 01/31/2012 | US8105842 Interleukin-13 as a cardiovascular disease marker |
| 01/31/2012 | US8105839 Diagnostic kit for Alzheimer's disease, diagnostic marker, and detection method for indicator of pathological state thereof |
| 01/31/2012 | US8105830 Polyspecific binding molecules and uses thereof |
| 01/31/2012 | US8105774 Using peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PGC-1Beta) as tool to identify modulators for treatment of free radical associated disorders |
| 01/31/2012 | US8105610 Method of making novel erythrovirus V9 VP2 capsid polypeptides |
| 01/31/2012 | US8105609 Administering a vaccine of a nucleic acid having a transcriiptional unit (TU) to direct a host cell to to biosynthesize the matrix and envelope (M and E) protein antigens; the TU comprises a prM signal sequence and ribosomal bindng sequence; carriers; encephalitis and yellow fever |
| 01/31/2012 | US8105607 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| 01/31/2012 | US8105599 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor |
| 01/31/2012 | US8105597 Aβ binding molecules |
| 01/31/2012 | US8105596 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 01/31/2012 | US8105595 Methods of using neutralizing anti-TLR4/MD2 antibodies |
| 01/31/2012 | US8105594 Methods for amyloid removal using anti-amyloid antibodies |
| 01/31/2012 | US8105593 Anti-ADDL monoclonal antibody and use thereof |
| 01/31/2012 | US8105591 Methods of antagonizing signal transduction in dorsal root ganglion cells |
| 01/31/2012 | US8105590 Methods of treating inflammation in neuronal tissue |
| 01/31/2012 | US8105589 Use of DR3 antibodies in the treatment of inflammatory disease |
| 01/31/2012 | US8105588 Human monoclonal antibodies against interleukin 8 (IL-8) |
| 01/31/2012 | US8105587 Methods of treating arthritis using IL-1β binding molecules |
| 01/31/2012 | US8105568 Vitamin receptor binding drug delivery conjugates |
| 01/31/2012 | US8105084 Interactive dental restorative network |
| 01/31/2012 | US8104533 Spray nozzle apparatus and method of use |
| 01/31/2012 | CA2443947C Recombinant p. vivax merozoite protein-1 p42 vaccine |
| 01/31/2012 | CA2380216C Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 01/31/2012 | CA2339889C Identification of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 01/31/2012 | CA2285672C Purified telomerase |
| 01/31/2012 | CA2274989C Cloned glucagon-like peptide-2 receptors |
| 01/31/2012 | CA2233670C Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof |
| 01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/26/2012 | WO2012012802A2 Neoepitope detection of disease using protein arrays |
| 01/26/2012 | WO2012012750A1 ANTI-DEsupR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY |
| 01/26/2012 | WO2012012531A2 Compositions and methods featuring il-6 and il-21 antagonists |
| 01/26/2012 | WO2012012469A2 Signal biomarkers |
| 01/26/2012 | WO2012012271A2 Novel glycosylated polypeptides |
| 01/26/2012 | WO2012012141A1 Scnn1a/tnfrsf1a fusion proteins in cancer |
| 01/26/2012 | WO2012011955A2 Compositions and methods for production and screening of monoclonal antibodies |
| 01/26/2012 | WO2012011396A1 Transgenic rice plant capable of expressing nanoantibody |
| 01/26/2012 | WO2012011144A2 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom. |
| 01/26/2012 | WO2012010855A1 Intracellular immunity |
| 01/26/2012 | WO2012010799A1 Formulation of anti-cd20 antibodies |
| 01/26/2012 | WO2012010696A1 Methods for cancer management targeting co-029 |
| 01/26/2012 | WO2012010674A1 Nkx2.2 inhibitors as drugs |
| 01/26/2012 | WO2012010635A1 Novel antigen binding proteins |
| 01/26/2012 | WO2012010602A1 Method to improve glycosylation profile and to induce maximal cytotoxicity for antibody |
| 01/26/2012 | WO2012010582A1 Anti-cxcr5 antibodies and methods of use |
| 01/26/2012 | WO2012010562A1 Anti-cd19 antibody having adcc and cdc functions and improved glycosylation profile |
| 01/26/2012 | WO2012010561A1 Anti-cd19 antibody having adcc function with improved glycosylation profile |
| 01/26/2012 | WO2012009977A1 FULLY HUMAN TNFα-FAB ANTIBODY AND PEGYLATED ANTIBODY THEREOF |
| 01/26/2012 | WO2012009790A1 Cross-protective pathogen protection, methods and compositions thereof |
| 01/26/2012 | WO2012009760A1 Anti-il-23 heterodimer specific antibodies |
| 01/26/2012 | WO2011127412A3 Soluble human st-2 antibodies and assays |
| 01/26/2012 | WO2011109726A3 Homologous multi-specific antibodies |
| 01/26/2012 | WO2011097527A3 Immunoprotection of therapeutic moieties using enhanced fc regions |
| 01/26/2012 | WO2011003557A8 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 01/26/2012 | US20120023600 Compositions and methods of use for antibodies of dickkopf-1 |
| 01/26/2012 | US20120022500 Compositions and Methods for Induced Brown Fat Differentiation |
| 01/26/2012 | US20120022239 Precipitation of biomolecules with negatively charged polymers |
| 01/26/2012 | US20120022238 Effector function enhanced recombinant antibody composition |
| 01/26/2012 | US20120022237 Peptides for treatment and diagnosis of bone diseases |
| 01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
| 01/26/2012 | US20120022128 PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis |
| 01/26/2012 | US20120022006 B-lymphocyte stimulator binding polypeptides and methods based thereon |
| 01/26/2012 | US20120021952 Focused libraries of genetic packages |
| 01/26/2012 | US20120021927 Methods for Determining a Prognosis for Survival for a Patient with Breast Cancer |
| 01/26/2012 | US20120021534 Markers for brain damage |
| 01/26/2012 | US20120021444 Method for diagnosis of cystic fibrosis using kl-6 levels |
| 01/26/2012 | US20120021437 Tetranor-pgdm/pgjm specific immunogens, antibodies, tracers, assay kits and methods for making same |
| 01/26/2012 | US20120021432 Phosphorylated NF45 Biomarkers, Antibodies And Methods Of Using Same |
| 01/26/2012 | US20120021431 Diagnostic methods using bnp |
| 01/26/2012 | US20120021405 Single Chain Antibody for the Detection of Noroviruses |
| 01/26/2012 | US20120020990 Isolated mammalian monocyte cell genes; related reagents |
| 01/26/2012 | US20120020988 Antibodies specifically binding to human TSLPR and methods of use |